Trypan blue-assisted peeling of the internal limiting membrane during macular hole surgery

American Journal of Ophthalmology

Volumn 135, Issue 6, 2003, Pages 903-905

  Perrier, Manuel ^a   Sébag, Mikaël ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRYPAN BLUE;

ADOLESCENT; ADULT; AGED; ANTERIOR EYE CHAMBER; ARTICLE; CILIARY DISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIRETINAL MEMBRANE; EYE SURGERY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MACULAR HOLE SURGERY; MALE; MEMBRANE DAMAGE; OUTCOMES RESEARCH; PHACOEMULSIFICATION; PILOT STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETINA MACULA HOLE; RETINA MACULA LUTEA; RETROSPECTIVE STUDY; RISK ASSESSMENT; STAINING; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

EID: 0037942926     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)02239-0     Document Type: Article

References (6)

1. Gardorfer A., Haritoglou C., Gass C.A., Ulbig M.W., Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol. 132:2001;431-433.
2. Engelbrecht N., Freeman J., Sternberg P., Aaberg T. Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol. 133:2002;89-94.
3. Schmidt K.L., Milner K., Hilburn P.J., Schmidt W.A. Ultrastructure of trypan blue induced ocular defects I. Retina and lens . Teratology. 28:1983;131-144.
4. Norn M.S. Per operative trypan blue vital staining of corneal endothelium. Eight years' follow up. Acta Ophthalmol. 58:1980;550-555.
5. Veckeneer M., van Overdam K., Monzer J., et al. Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes. Graefes Arch Clin Exp Ophthalmol. 239:2001;698-704.
6. Feron E., Veckeneer M., Parys-Van Ginderdeuren R., et al. Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy. Arch Ophthalmol. 120:2002;141-144.